SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 144 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $295,442 | +23.6% | 2,280 | +34.1% | 0.08% | +48.1% |
| Q3 2020 | $239,000 | -96.4% | 1,700 | -96.7% | 0.05% | -85.3% |
| Q4 2019 | $6,655,000 | +67.8% | 51,574 | -2.1% | 0.35% | +68.9% |
| Q3 2019 | $3,967,000 | -41.0% | 52,674 | +3.6% | 0.21% | -55.2% |
| Q2 2018 | $6,722,000 | +972.1% | 50,854 | +173.2% | 0.47% | +418.9% |
| Q2 2017 | $627,000 | +29.8% | 18,614 | -26.4% | 0.09% | -45.8% |
| Q2 2016 | $483,000 | +237.8% | 25,302 | +583.8% | 0.17% | +71.1% |
| Q4 2015 | $143,000 | +1000.0% | 3,700 | +825.0% | 0.10% | +781.8% |
| Q3 2015 | $13,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |